These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25478253)

  • 1. Managing a Rivaroxaban Bleed: Understanding the Difficulties in Acute Reversal of the New Oral Anticoagulants through a Case Report.
    Nannapaneni N; Singh R; Mckay P; Al-Hajeili M
    Case Rep Hematol; 2014; 2014():548272. PubMed ID: 25478253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing reversal of direct oral anticoagulants in emergency situations. Anticoagulation Education Task Force White Paper.
    Ageno W; Büller HR; Falanga A; Hacke W; Hendriks J; Lobban T; Merino J; Milojevic IS; Moya F; van der Worp HB; Randall G; Tsioufis K; Verhamme P; Camm AJ
    Thromb Haemost; 2016 Nov; 116(6):1003-1010. PubMed ID: 27488232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergent Reversal of Direct Oral Anticoagulants Permitting Neurosurgical Intervention for Nonhemorrhagic Pathology.
    Sherrod BA; Condie CK; Brock AA; Ledyard H; Menacho ST; Mazur MD
    World Neurosurg; 2020 Mar; 135():38-41. PubMed ID: 31809896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of stroke- and bleed-related healthcare resource utilization and costs among patients with newly diagnosed non-valvular atrial fibrillation and newly treated with dabigatran, rivaroxaban, or warfarin.
    Gilligan AM; Franchino-Elder J; Song X; Wang C; Henriques C; Sainski-Nguyen A; Wilson K; Smith DM; Sander S
    Expert Rev Pharmacoecon Outcomes Res; 2019 Apr; 19(2):203-212. PubMed ID: 30251553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tonsillectomy on rivaroxaban.
    Saini AT; Schorn VJ; Lin FY
    Am J Otolaryngol; 2015; 36(2):280-2. PubMed ID: 25456169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct-Acting Oral Anticoagulants and Their Reversal Agents-An Update.
    Kustos SA; Fasinu PS
    Medicines (Basel); 2019 Oct; 6(4):. PubMed ID: 31618893
    [No Abstract]   [Full Text] [Related]  

  • 7. Intraoperative Unfractionated Heparin Unresponsiveness during Endovascular Repair of a Ruptured Abdominal Aortic Aneurysm following Administration of Andexanet Alfa for the Reversal of Rivaroxaban.
    Eche IM; Elsamadisi P; Wex N; Wyers MC; Brat GA; Cunningham K; Bauer KA
    Pharmacotherapy; 2019 Aug; 39(8):861-865. PubMed ID: 31251821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring and reversal strategies for new oral anticoagulants.
    Vanden Daelen S; Peetermans M; Vanassche T; Verhamme P; Vandermeulen E
    Expert Rev Cardiovasc Ther; 2015 Jan; 13(1):95-103. PubMed ID: 25431993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor Eight Inhibitor Bypassing Agent (FEIBA) for Reversal of Target-Specific Oral Anticoagulants in Life-Threatening Intracranial Bleeding.
    Mao G; King L; Young S; Kaplan R
    J Emerg Med; 2017 May; 52(5):731-737. PubMed ID: 28007364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid evidence assessment of bleed-related healthcare resource utilization in publications reporting the use of direct oral anticoagulants for non-valvular atrial fibrillation.
    Shah BR; Scholtus E; Rolland C; Batscheider A; Katz JN; Nilsson KR
    Curr Med Res Opin; 2019 Jan; 35(1):127-139. PubMed ID: 30380959
    [No Abstract]   [Full Text] [Related]  

  • 11. Managing patients taking edoxaban in dentistry.
    Curto A; Curto D; Sanchez J
    J Clin Exp Dent; 2017 Feb; 9(2):e308-e311. PubMed ID: 28210454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo reversal of effects of rivaroxaban evaluated using thromboelastometry and thrombin generation assay.
    Schenk B; Würtinger P; Streif W; Sturm W; Fries D; Bachler M
    Br J Anaesth; 2016 Nov; 117(5):583-591. PubMed ID: 27623677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral anticoagulation with Factor Xa and thrombin inhibitors: Is there an alternative to warfarin?
    Zikria J; Ansell J
    Discov Med; 2009 Dec; 8(43):196-203. PubMed ID: 20040270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro.
    Perzborn E; Heitmeier S; Laux V; Buchmüller A
    Thromb Res; 2014 Apr; 133(4):671-81. PubMed ID: 24529498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of the Pharmacology of the Emerging Possibilities of the Direct Oral Anticoagulants' Reversal.
    Samos M; Stanciakova L; Skornova I; Bolek T; Kovar F; Stasko J; Galajda P; Mokan M; Kubisz P
    Curr Drug Metab; 2017; 18(7):643-650. PubMed ID: 28412907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of Anticoagulation and Management of Bleeding in Patients on Anticoagulants.
    Dhakal P; Rayamajhi S; Verma V; Gundabolu K; Bhatt VR
    Clin Appl Thromb Hemost; 2017 Jul; 23(5):410-415. PubMed ID: 27789605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Severe Bleeding in Patients Treated With Oral Anticoagulants: Proceedings Monograph From the Emergency Medicine Cardiac Research and Education Group-International Multidisciplinary Severe Bleeding Consensus Panel October 20, 2018.
    Gibler WB; Racadio JM; Hirsch AL; Roat TW
    Crit Pathw Cardiol; 2019 Sep; 18(3):143-166. PubMed ID: 31348075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current state of knowledge on oral anticoagulant reversal using procoagulant factors.
    Nitzki-George D; Wozniak I; Caprini JA
    Ann Pharmacother; 2013 Jun; 47(6):841-55. PubMed ID: 23695644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
    Cohen AT; Hamilton M; Mitchell SA; Phatak H; Liu X; Bird A; Tushabe D; Batson S
    PLoS One; 2015; 10(12):e0144856. PubMed ID: 26716830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing bleeding and emergency reversal of newer oral anticoagulants: a review for primary care providers.
    Peacock WF
    Hosp Pract (1995); 2014 Oct; 42(4):75-82. PubMed ID: 25502131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.